Combs Andrew

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -19% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Combs Andrew's trades of Prelude Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-27 2025-03-25
PP Planned purchase
64,120 +19.8%
446.80
US$1,368,023 		64,120 +19.8% 446.80 US$1,368,023
2024-12-26 2024-12-23
B Purchase
11,172 -1.6%
236.57
US$112,320 		11,172 -1.6% 236.57 US$112,320
2024-12-26 2024-12-20
PP Planned purchase
4,628 -10.4%
114.02
US$639,713 		4,628 -10.4% 114.02 US$639,713
2021-12-15 2021-12-14
B Purchase
4,000 +1.5%
11.60
US$46,400 		4,000 +1.5% 11.60 US$46,400
2021-12-15 2021-12-13
B Purchase
4,000 +1.5%
12.12
US$48,480 		4,000 +1.5% 12.12 US$48,480
2020-09-29 2020-09-29
B Purchase
1,000 +0.4%
19.00
US$19,000 		1,000 +0.4% 19.00 US$19,000